Utilization of Noninvasive Tests to Diagnose At-Risk Metabolic Dysfunction-Associated Steatohepatitis

G&H  Why is it important to diagnose at-risk metabolic dysfunction-associated steatohepatitis? MN  Metabolic dysfunction-associated steatohepatitis (MASH; formerly known as nonalcoholic steatohepatitis) is prevalent in the United […]

The Gut Microbiome and Nonalcoholic Steatohepatitis

G&H  What makes up a healthy microbiome?  JS  A healthy microbiome is not completely identical in every person. It is influenced by the type of diet, […]

Current Management and Future Treatment of Alcoholic Hepatitis

  Abstract: Excessive alcohol consumption is responsible for approximately 50% of all deaths due to cirrhosis. Although the duration and amount of alcohol consumption are the […]

Role of Noninvasive Biomarkers in the Diagnosis of Nonalcoholic Steatohepatitis With Stage 2 or 3 Fibrosis

  G&H  Why is the stage of fibrosis important in nonalcoholic steatohepatitis? RL  Patients with nonalcoholic fatty liver disease (NAFLD) can be divided into 2 broad […]

Diagnosis of Nonalcoholic Steatohepatitis Without Liver Biopsy

  G&H  What is the relationship between nonalcoholic steatohepatitis and nonalcoholic fatty liver disease, and how common are these conditions? BM  Nonalcoholic fatty liver disease (NAFLD) […]

Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials

  Abstract: Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of liver disease in developed countries, and the rates of NAFLD continue to rise […]

Millennium Medical Publishing, Inc